TCT 2025

February 12-15, 2025
Honolulu, Hawaii, USA

2025 Tandem Transplantation & Cellular Therapy Meetings of ASTCT and CIBMTR

Explore more Hematology-Oncology congress materials

Results(1)

Hematology

Treatment Duration, Symptom Resolution, and Survival in Defibrotide-Treated Patients With Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome by Exposure to Inotuzumab Ozogamicin or Gemtuzumab Ozogamicin

Author(s): Mohamad Mohty, Franco Locatelli, Régis Peffault de Latour et al.

Disclaimer

This AI model is continuing to learn and its responses are based on learned data patterns. It should not replace professional judgment. Please verify the information before use, and feedback is welcome to improve its accuracy.

Please do not include personal or confidential information in your searches. For information on how to report an adverse event or product complaint for a Jazz product, please visit: https://www.jazzpharma.com/medicines/drug-safety/.